NPs Basic Information

Name
Asperentin-8-methyl ether
Molecular Formula C17H22O5
IUPAC Name*
6-hydroxy-8-methoxy-3-[[(2R,6S)-6-methyloxan-2-yl]methyl]-3,4-dihydroisochromen-1-one
SMILES
C[C@H]1CCC[C@@H](O1)CC2CC3=C(C(=CC(=C3)O)OC)C(=O)O2
InChI
InChI=1S/C17H22O5/c1-10-4-3-5-13(21-10)9-14-7-11-6-12(18)8-15(20-2)16(11)17(19)22-14/h6,8,10,13-14,18H,3-5,7,9H2,1-2H3/t10-,13+,14?/m0/s1
InChIKey
COFDRZBGPVKKJQ-CMVMAMJTSA-N
Synonyms
asperentin-8-methyl ether; asperentin 8-O-methylether; cladosporin 8-O-methylether; CHEBI:68703; Q27137123; 6-hydroxy-8-methoxy-3-{[(2R,6S)-6-methyltetrahydro-2H-pyran-2-yl]methyl}-3,4-dihydro-1H-isochromen-1-one
CAS NA
PubChem CID 71728345
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Benzopyrans
        • Subclass: 2-benzopyrans
          • Direct Parent: 2-benzopyrans

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 306.4 ALogp: 3.0
HBD: 1 HBA: 5
Rotatable Bonds: 3 Lipinski's rule of five: Accepted
Polar Surface Area: 65.0 Aromatic Rings: 3
Heavy Atoms: 22 QED Weighted: 0.864

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.665 MDCK Permeability: 0.00005470
Pgp-inhibitor: 0.005 Pgp-substrate: 0.003
Human Intestinal Absorption (HIA): 0.003 20% Bioavailability (F20%): 0.004
30% Bioavailability (F30%): 0.014

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.518 Plasma Protein Binding (PPB): 68.95%
Volume Distribution (VD): 0.964 Fu: 8.68%

ADMET: Metabolism

CYP1A2-inhibitor: 0.437 CYP1A2-substrate: 0.424
CYP2C19-inhibitor: 0.246 CYP2C19-substrate: 0.768
CYP2C9-inhibitor: 0.082 CYP2C9-substrate: 0.902
CYP2D6-inhibitor: 0.245 CYP2D6-substrate: 0.793
CYP3A4-inhibitor: 0.621 CYP3A4-substrate: 0.224

ADMET: Excretion

Clearance (CL): 13.125 Half-life (T1/2): 0.516

ADMET: Toxicity

hERG Blockers: 0.018 Human Hepatotoxicity (H-HT): 0.807
Drug-inuced Liver Injury (DILI): 0.705 AMES Toxicity: 0.308
Rat Oral Acute Toxicity: 0.017 Maximum Recommended Daily Dose: 0.976
Skin Sensitization: 0.91 Carcinogencity: 0.903
Eye Corrosion: 0.014 Eye Irritation: 0.579
Respiratory Toxicity: 0.72
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC003280 0.779 D0X5KF 0.289
ENC002387 0.585 D07MGA 0.281
ENC003043 0.577 D0T6RC 0.276
ENC003297 0.557 D09PJX 0.273
ENC002298 0.532 D03SKD 0.270
ENC005004 0.532 D0L1JW 0.268
ENC003715 0.519 D0NS6H 0.265
ENC005001 0.500 D00ZFP 0.253
ENC003973 0.494 D04TDQ 0.246
ENC003318 0.483 D04JHN 0.245
*Note: the compound similarity was calculated by RDKIT.